Is that what it was
PubMed Johansen, P.B., Nowak, J., Skjaerbaek, C., Flyvbjerg, A., Andreassen, T.T., Wilken, M., & rskov, H
This is why the authoritative source for your own protocol is never a general article but the paperwork that accompanies your prescription
Meanwhile, it is important to note that there is a concern that prolonged use of angiogenesis-promoting agents, such as BPC-157, TB-500, and GHK-Cu, might have the potential for complications, which are discussed in peptide safety articles also published on Peptides.org
For anyone reconstituting a peptide they plan to use over several weeks such as BPC-157, TB-500, or CJC-1295/Ipamorelin this difference alone often decides which solution makes sense